BioNTech SE (BNTX) Change in Intangibles (2024 - 2025)

BioNTech SE (BNTX) posted Change in Intangibles of $1.3 million for Q4 2025, up 140.57% sequentially from -$3.2 million in Q3 2025, and up 104.89% YoY from $624941.5 in Q4 2024.

BioNTech SE (BNTX) Change in Intangibles (2024 - 2025) Analysis & Trends

BioNTech SE has reported Change in Intangibles for 2 years, with the latest figure at $1.3 million in Q4 2025.

  • Quarterly Change in Intangibles rose 104.89% year-over-year to $1.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$672.4 million (changed N/A YoY) and the FY2025 annual result came in at -$648.4 million, down 265.97% from the prior year.
  • Change in Intangibles climbed to $1.3 million in Q4 2025 per BNTX's latest filing, from -$3.2 million in the prior quarter.
  • Over five years, Change in Intangibles peaked at $1.3 million in Q4 2025 and troughed at -$644.3 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Intangibles (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn -
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn -
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -
10 BioNTech SE 23.54 Bn 5.15 Bn 668.28 Mn 1.28 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 1.28 Mn
Dec 31, 2025 1.28 Mn
Sep 30, 2025 -3.16 Mn
Sep 30, 2025 -3.16 Mn
Jun 30, 2025 -644.31 Mn
Jun 30, 2025 -644.31 Mn
Dec 31, 2024 -26.18 Mn
Dec 31, 2024 -26.18 Mn
Sep 30, 2024 -11.20 Mn
Sep 30, 2024 -11.20 Mn
Jun 30, 2024 -84.43 Mn
Jun 30, 2024 -84.43 Mn